articleTop 1% cited
Topiramate in migraine prophylaxis
Journal of Neurology · 2004 · Vol. 251(8) · pp. 943–50
Hans‐Christoph Diener✉(Essen University Hospital)P Tfelt-Hansen(University of Copenhagen)C. Dahl�fM.J.A. L�inezGiorgio Sandrini(University of Pavia)Sh.-J. Wang(National Yang Ming Chiao Tung University)Walter Krause Neto(Johnson & Johnson (United States))Ujjwala Vijapurkar(Johnson & Johnson (United States))Ana Doyle(Johnson & Johnson (United States))David E. Jacobs(Johnson & Johnson (United States))on behalf of the MIGR-003 Study Group
Migraine and Headache StudiesTrigeminal Neuralgia and TreatmentsOphthalmology and Eye DisordersTopiramateNeurologyNeuroradiologyMigraineMedicineMigraine DisordersPediatricsAnesthesiaPsychiatryEpilepsy
MeSH terms
TopiramateAdultAnticonvulsantsDose-Response Relationship, DrugDouble-Blind MethodDrug EvaluationFemaleFructoseHumansMaleMiddle AgedMigraine DisordersPropranololProspective StudiesTime Factors
Citations
343
FWCI
15.45
field-weighted impact
References
15
Percentile
100%
vs. same field & year
Citations per year
References
Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) [RETIRED]
Neurology · 2000 · 1,358 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.